NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.

Enabling real-world sample collection in oncology diagnostic study with local clinics as trial sites

lorem ipsum

Get the case study

Cofactor partnered with Curebase in a study looking to observe the effectiveness of oncology indication technology used to predict tumor response to certain treatments like immunotherapy. This ongoing study needed to collect tumor biopsy samples in oncology clinics where qualified patients were likely to be. To do this Curebase implemented a flexible study model that activated several local oncology clinics allowing the Sponsor to collect data in real-world settings by bringing this oncology diagnostic study to where qualified patients were

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States